Events
Forging a Path for Early Clinical Development in Sickle Cell Disease
Distinguished Pfizer researchers David Beidler and Debra Pittman share their experience in Sickle Cell Disease including: Using longitudinal…
Biobanking Today: Facebook, Crypto, Artificial Intelligence
Sanguine partners with patients and leverages their health data to accelerate your research for their condition. By working…
Simplifying Patient Participation
Research depends on samples from patients and healthy volunteers. However, obtaining biospecimens from human subjects can be a…
Implementing AI: The Effects of AI in Drug Development
Join our distinguished Novartis speaker, Shruthi Bharadwaj, PhD as she speaks about her experience in AI including: With…
Biospecimen Donation: Personal Journey of a Family and Genetic Diagnostic Lab Advancing Biomedical Research
Speakers: Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science Arupa…
COVID-19: Navigating the Pandemic: – How with COVID-19 effect research studies and clinical trials?
COVID-19 has spread to more than 60 countries, causing tens of thousands of illnesses and thousands of…
COVID-19: Navigating the Pandemic: COVID-19’s potential impact on the global pharmaceutical market?
COVID-19 has spread to more than 60 countries, causing tens of thousands of illnesses and thousands of deaths.…
The Journey from Patient to Advocate to Leader: Changing the Clinical Research Game
Rob Long, Executive Director, Uplifting Athletes I will talk about my journey from Division I football and top…
Navigating the Pandemic: How will COVID-19 change R&D?
COVID-19 has put the biopharma industry into a tailspin – big pharma, biotech and small startups are all…
PFE-001: A Novel Non-Covalent Modulator of Hemoglobin Improves Anemia and Reduces Sickling in a Mouse Model of Sickle Cell Disease
Kelly M. Knee, PhD, Senior Principal Scientist, Rare Disease Researcher Unit, Pfizer Sickle cell disease is a…